The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback